Enable JavaScript Multimedia | Portal Regional da BVS
Portal Regional da BVS

Portal Regional da BVS

Virtual Health Library (VHL = BVS) – integrated search with LILACS and VHL databases

Resources found: 7

Minitaller sobre la aceptación y el uso de las vacunas en el contexto de la seguridad de las mismas

Mitos sobre vacunación y COVID-19

Entender cómo piensa, se posiciona y actúa la gente sobre la vacunación es fundamental para informar el desarrollo de estrategias para la aceptación y el uso de las vacunas. La generación y el uso de datos sobre los factores sociales y de comportamiento implicados requiere un conjunto de herramientas -encuestas, guías de entrevistas, herramientas y marcos relacionados- para apoyar la recopil...
See more details

Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Access to Essential Medicines and Health Technologies, Health Equity, Viral Vaccines/adverse effects, Health Communication, Communication, Health Systems/organization & administration, Social Participation, Vaccine Potency, Risk Groups, Quarantine, Social Isolation, COVID-19, Infodemia

Mito: "las vacunas no funcionan contra nuevas variantes q empezaron a detectarse, como la de Brasil"

Mitos sobre vacunación y COVID-19

Serie: Respuesta de la ciencia a los mitos más escuchados sobre vacunación y #COVID19​ Dr. Juan Arbiza. Investigador Grado 5 de Primer nivel del Programa de Posgrado en Ciencias Básicas (PEDECIBA) –UdelaR. Integra el Grupo Asesor Científico Honorario (GACH) de la Presidencia de la República. Profesor Titular de Virología con Dedicación exclusiva. Facultas de Ciencias. Investigador Niv...
See more details

Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/immunology, Immunization Programs/organization & administration, Health Communication, Vaccine Potency, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, DNA, Viral/genetics, Mutation/genetics, COVID-19, Mito

Mito: "la P1 es mucho más agresiva que las otras variantes de COVID-19​"

Mitos sobre vacunación y COVID-19

Serie: Respuesta de la ciencia a los mitos más escuchados sobre vacunación y #COVID19​ Dra. Lucia Alonso. Epidemióloga. Consultora de OPS. Integra el Grupo Asesor Científico Honorario (GACH) de la Presidencia de la República y también el Comité de Emergencia para COVID-19 que asesora al director general de la Organización Mundial de la Salud (OMS), es profesora adjunta en el Departamen...
See more details

Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/immunology, Immunization Programs/organization & administration, Health Communication, Vaccine Potency, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, DNA, Viral/genetics, Mutation/genetics, COVID-19, Mito, Variante P1

Mito: "estas vacunas no nos van a proteger contra la P1"

Mitos sobre vacunación y COVID-19

Serie: Respuesta de la ciencia a los mitos más escuchados sobre vacunación y #COVID19​ Dra. Lucia Alonso. Epidemióloga. Consultora de OPS. Integra el Grupo Asesor Científico Honorario (GACH) de la Presidencia de la República y también el Comité de Emergencia para COVID-19 que asesora al director general de la Organización Mundial de la Salud (OMS), es profesora adjunta en el Departamen...
See more details

Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/immunology, Immunization Programs/organization & administration, Health Communication, Vaccine Potency, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, DNA, Viral/genetics, Mutation/genetics, COVID-19, Mito, Variante P1

Media briefing on COVID-19 - 26/03/2021

Coronavírus - WHO

00:00:18 CL Hello. Good day to... wherever you are listening to us. Today is Friday 26th March 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference. Simultaneous interpretation is provided in the six official UN languages, Arabic, Chinese, French, English, Spanish and Russian, as well as Portuguese and Hindi. The participants today are, p...
See more details

Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Health Communication, Risk Groups, Health Equity, Hospital Bed Capacity, Intensive Care Units, Americas/epidemiology, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Viral Vaccines/immunology, Vaccine Potency, Mutation/genetics, DNA, Viral/genetics, COVID-19, Ghebreyesus, Tedros Adhanom , Covax

WHO’s Science in 5 on COVID-19: vaccines, variants & doses

Science in 5

If you have already had COVID-19 do you still need both doses of the vaccine? Do these vaccines protect you against infection? Do they protect us against variants? WHO’s Dr Katherine O’Brien answers these questions in Science in 5 this week.
See more details

Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/immunology, Immunization Programs/organization & administration, Vaccine Potency, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Health Communication, COVID-19

COVID-19​ live Q&A with Dr Mike Ryan and Dr Maria Van Kerkhove. Ask WHO​ of 6 January 2021

COVID-19 Q&A Ask WHO live series

#AskWHO​ series: This was the live discussion about the COVID-19 pandemic of 6 January 2021 with Dr Mike Ryan, Executive Director of WHO Health Emergencies Programme, and Dr Maria Van Kerkhove, WHO Technical Lead on COVID-19. Questions from the audience were taken.
See more details

Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Social Isolation, Quarantine, Pandemics/prevention & control, Epidemiological Monitoring, Health Communication, Holidays, Americas/epidemiology, Risk Groups, Betacoronavirus/immunology, Viral Vaccines/immunology, Immunization Programs/organization & administration, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Masks, Betacoronavirus/genetics, Pneumonia, Viral/genetics, Coronavirus Infections/genetics, DNA, Viral/genetics, Mutation/genetics, Vaccine Potency, COVID-19
...